Palo Alto, CA, United States of America

Eric Day


 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Eric Day and His Contributions to JCV Research

Introduction

Eric Day is a notable inventor based in Palo Alto, California. He holds a patent for his groundbreaking work in the field of neutralizing antibodies against the JC virus (JCV). His innovative approach and dedicated research have the potential to significantly impact the treatment of progressive multifocal leukoencephalopathy (PML).

Latest Patents

Eric Day's patent involves the development of neutralizing antibodies against JCV, specifically focusing on an isolated JC virus neutralizing monoclonal antibody against the JCV capsid protein VPI (JCV-VP1). This invention provides methods for treating PML by suppressing the infectivity of the JC virus. The antibody is designed to bind to the sialic acid binding pocket of JCV-VP1, enhancing its therapeutic potential.

Career Highlights

Eric Day is affiliated with Biogen MA Inc., a leading biotechnology company that is at the forefront of developing innovative treatments for severe diseases. His role at Biogen MA Inc. allows him to work on pioneering research projects that aim to improve patient outcomes, particularly in the realm of viral infections and neurological complications.

Collaborations

Throughout his career, Eric has collaborated with esteemed colleagues, including Kenneth J. Simon and Thomas O. Cameron. These partnerships bring together a wealth of experience and expertise, contributing to the advancement of research in JCV and its associated treatments.

Conclusion

Eric Day's contributions to the biomedical field through his invention of neutralizing antibodies against JCV demonstrate the importance of innovation in addressing critical health challenges. His work not only reflects his commitment to scientific advancement but also highlights the collaborative spirit that drives progress in the medical research community. As research continues to evolve, Eric Day's achievements will undoubtedly influence future developments in the treatment of viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…